Stocktoria

IRONWOOD PHARMACEUTICALS INC IRWD

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2010-02-03 · LEI

IRONWOOD PHARMACEUTICALS INC statistics & valuation

Market cap$679.9M
P / E28.3×
P / S2.3×
P / FCF5.4×
Net margin8.1%
FCF margin42.9%
Return on capital63.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-29.80% -39.20% -81.50% 5.00% 27.30% 127.70% 42.60% -226.40% 0.30% 8.10% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-18.90% -5.20% -43.50% 28.00% 36.70% 56.10% 61.00% -213.50% 26.50% 33.30% 2016201720182019202020212022202320242025
Return on equity (%)
-122.50% -1187.40% 169.50% 87.20% 26.80% 2016201720182019202020212022202320242025
Shares outstanding
154.4M 157.5M 160.7M 164.4M 186.3M 156.4M 160.2M 163.1M 2016201720182019202020212022202320242025
Net debt ($)
$67.7M -$165.9M -$260.0M $305.7M $110.4M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-11.50% -19.30% -85.00% 5.30% 19.00% 46.90% 15.90% -212.80% 0.30% 6.10% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-11.00% -37.20% -24.00% 0.80% 42.90% 63.20% 66.60% 41.40% 29.40% 42.90% 2016201720182019202020212022202320242025
Debt / equity (×)
6.87× 0.75× 0.61× 2016201720182019202020212022202320242025
EPS ($)
-$1.85 $0.14 $0.66 $3.21 $0.96 -$6.45 $0.01 $0.15 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

IRONWOOD PHARMACEUTICALS INC trades at about 28.8× earnings — below its 10-year norm (10-year range 3.5×–234×, median 32.6×).

3.5× 234×

Shaded band = 10-year range (3.5×–234×); dot = today's 28.8×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin33.3%26.5%-213.5%61.0%56.1%36.7%28.0%-43.5%-5.2%-18.9%
Net margin8.1%0.3%-226.4%42.6%127.7%27.3%5.0%-81.5%-39.2%-29.8%
FCF margin42.9%29.4%41.4%66.6%63.2%42.9%0.8%-24.0%-37.2%-11.0%
Return on assets6.1%0.3%-212.8%15.9%46.9%19.0%5.3%-85.0%-19.3%-11.5%
Return on equity-9.2%-0.3%289.4%26.8%87.2%169.5%-23.1%143.8%-1187.4%-122.5%
Debt / equity—-0.66×-1.15×0.61×0.75×6.87×————
Current ratio1.134.690.8430.584.6115.417.502.234.724.17

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.